Collegium Pharmaceutical Inc (COLL) — Cash Flow-to-Debt Ratio
Collegium Pharmaceutical Inc (COLL) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of $78.44 Million could theoretically repay 0% of its total liabilities ($1.33 Billion) in one year. Check Collegium Pharmaceutical Inc (COLL) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Collegium Pharmaceutical Inc Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Collegium Pharmaceutical Inc across 12 annual periods. Also explore COLL asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Collegium Pharmaceutical Inc (2013–2024)
Year-by-year debt coverage analysis for Collegium Pharmaceutical Inc. For market capitalisation and broader financial context, see COLL market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | $204.98 Million | $1.43 Billion | ▼ -50.7% |
| 2023 | 0.29x | $274.75 Million | $947.88 Million | ▲ +128.5% |
| 2022 | 0.13x | $124.23 Million | $979.29 Million | ▼ -40.1% |
| 2021 | 0.21x | $103.56 Million | $489.15 Million | ▲ +3.2% |
| 2020 | 0.21x | $93.94 Million | $457.81 Million | ▲ +61.7% |
| 2019 | 0.13x | $27.78 Million | $218.87 Million | ▼ -85.0% |
| 2018 | 0.85x | $169.39 Million | $199.66 Million | ▲ +139.9% |
| 2017 | -2.13x | $-67.02 Million | $31.49 Million | ▲ +23.1% |
| 2016 | -2.77x | $-75.05 Million | $27.11 Million | ▼ -62.3% |
| 2015 | -1.71x | $-21.57 Million | $12.65 Million | ▼ -64.7% |
| 2014 | -1.04x | $-17.95 Million | $17.33 Million | ▲ +78.4% |
| 2013 | -4.79x | $-16.53 Million | $3.45 Million | — |